Latest AI and machine learning research in skin cancer for healthcare professionals.
While gene sequencing is routine in cancer care, translating sequences into treatment decisions remains a challenge. Here we introduce MutationProjector, an AI foundation model that transforms tumor mutation profiles into a compact representation of cancer subtype, with broad implications for diagnosis and therapy. MutationProjector is pre-trained by integrating genomic alterations from >30,000 tu...
Linking spatial transcriptomic data to clinically relevant phenotypes is essential for advancing spatially informed precision oncology. Here, we present SpaPheno, an interpretable machine learning framework that integrates spatial transcriptomics with clinically annotated bulk RNA-seq to identify spatially resolved biomarkers predictive of patient outcomes, including survival, tumor stage, and imm...
B-cells get activated through interaction with B-cell epitopes, a specific portion of the antigen. Identification of B-cell epitopes is crucial for a ...
Reconstructing individual patient data (IPD) from Kaplan–Meier (KM) plots provides valuable insights for evidence synthesis in clinical research. Howe...
Biological systems can be interrogated by perturbing individual components and observing the consequences across molecular, cellular, and phenotypic l...
Machine learning models trained on paratope-similarity networks have shown superior accuracy compared with clonotype-based models in binary disease cl...
Here we are introducing CryoPhold, a modular workflow that unifies AlphaFold-based ensemble generation, Bayesian reweighting against experimental cryo...
The ability to predict T cell receptor (TCR) specificity from sequence could transform immunotherapy, vaccine development, and our understanding of im...
T cells recognize and eliminate diseased cells by binding their T cell receptors (TCRs) to short endogenous peptides (antigens) presented on the cell ...
The adaptive immune system monitors cellular integrity by recognizing short peptides from intracellular proteins presented on Major Histocompatibility...
Brain metastasis (BrM) is a serious complication of advanced cancers and remains difficult to predict before clinical symptoms appear. To investigate ...
Formalin-fixed paraffin-embedded (FFPE) tissues are widely used in clinical and research settings, yet their use for detecting somatic mutations from ...
Glioblastoma (GBM), the most aggressive primary brain tumor in adults, exhibits profound treatment resistance and poor prognosis. Despite advances in ...
Understanding the spatiotemporal dynamics of T-cell clones is a critical challenge in immunology and immunotherapy, with direct implications for cance...
T cell exhaustion limits the efficacy of cancer immunotherapies. Here, we performed genome-wide loss-of-function screening in repetitively stimulated ...
Current DNA damage repair (DDR) biomarkers employ binary classifications that fail to capture the molecular complexity of tumors with concurrent repai...
Spatially resolved omics enable the discovery of tissue organization of biological or clinical importance. Despite the existence of several methods, p...
The rational design of high-specificity binders to peptide–HLA (pHLA) complexes remains a major challenge in personalized immunotherapy, particularly ...
Tumor Mutational Burden (TMB) is a widely used biomarker for selecting cancer patients for immune checkpoint inhibitor (ICI) therapy. However, TMB alo...
Accurate in silico identification of B-cell epitope residues is crucial for antibody design and structure-guided vaccine development. Although recent ...